Imipramine inhibition of TRPM‐like plasmalemmal Mg2+ transport in vascular smooth muscle cells

Depression is associated with vascular disease, such as myocardial infarction and stroke. Pharmacological treatments may contribute to this association. On the other hand, Mg²⁺ deficiency is also known to be a risk factor for the same category of diseases. In the present study, we examined the effect of imipramine on Mg²⁺ homeostasis in vascular smooth muscle, especially via melastatin‐type transient receptor potential (TRPM)‐like Mg²⁺‐permeable channels. The intracellular free Mg²⁺ concentration (Mg²⁺]_i) was measured using ³¹P‐nuclear magnetic resonance (NMR) in porcine carotid arteries that express both TRPM6 and TRPM7, the latter being predominant. pH_i and intracellular phosphorus compounds were simultaneously monitored. To rule out Na⁺‐dependent Mg²⁺ transport, and to facilitate the activity of Mg²⁺‐permeable channels, experiments were carried out in the absence of Na⁺ and Ca²⁺. Changing the extracellular Mg²⁺ concentration to 0 and 6 mM significantly decreased and increased Mg²⁺]_i, respectively, in a time‐dependent manner. Imipramine statistically significantly attenuated both of the bi‐directional Mg²⁺]_i changes under the Na⁺‐ and Ca²⁺‐free conditions. This inhibitory effect was comparable in influx, and much more potent in efflux to that of 2‐aminoethoxydiphenyl borate, a well‐known blocker of TRPM7, a channel that plays a major role in cellular Mg²⁺ homeostasis. Neither ATP]_i nor pH_i correlated with changes in Mg²⁺]_i. The results indicate that imipramine suppresses Mg²⁺‐permeable channels presumably through a direct effect on the channel domain. This inhibitory effect appears to contribute, at least partially, to the link between antidepressants and the risk of vascular diseases.